Yingjun Xie

820 total citations · 1 hit paper
20 papers, 623 citations indexed

About

Yingjun Xie is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yingjun Xie has authored 20 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Yingjun Xie's work include MicroRNA in disease regulation (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cancer-related molecular mechanisms research (3 papers). Yingjun Xie is often cited by papers focused on MicroRNA in disease regulation (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cancer-related molecular mechanisms research (3 papers). Yingjun Xie collaborates with scholars based in China, United States and Maldives. Yingjun Xie's co-authors include Xuewen Zhang, Xiaoxiao Yao, Dan Zhang, Ranji Cui, Mengying Cui, Hongdan Wang, Dan Zhang, Xiaoxiao Yao, Yongsheng Yang and Jiyao Sheng and has published in prestigious journals such as Scientific Reports, BioMed Research International and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Yingjun Xie

16 papers receiving 618 citations

Hit Papers

Circulating MicroRNAs in ... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingjun Xie China 11 423 366 121 76 54 20 623
Buqing Sai China 11 524 1.2× 402 1.1× 168 1.4× 98 1.3× 101 1.9× 23 746
Bingjie Zeng China 9 667 1.6× 527 1.4× 132 1.1× 60 0.8× 165 3.1× 21 892
Ailin Qu China 16 541 1.3× 563 1.5× 66 0.5× 76 1.0× 34 0.6× 21 752
Jingxin Ding China 16 686 1.6× 597 1.6× 81 0.7× 25 0.3× 65 1.2× 41 925
Wenhao Ren China 15 511 1.2× 367 1.0× 111 0.9× 118 1.6× 53 1.0× 56 708
Pezhman Fard‐Esfahani Iran 16 405 1.0× 277 0.8× 80 0.7× 40 0.5× 23 0.4× 44 670
Guozhong Jiang China 15 405 1.0× 243 0.7× 220 1.8× 111 1.5× 85 1.6× 43 668
Xiaoxiao Yao China 8 316 0.7× 295 0.8× 81 0.7× 66 0.9× 32 0.6× 11 471
Zhengchuan Niu China 16 382 0.9× 278 0.8× 240 2.0× 72 0.9× 99 1.8× 29 698

Countries citing papers authored by Yingjun Xie

Since Specialization
Citations

This map shows the geographic impact of Yingjun Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingjun Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingjun Xie more than expected).

Fields of papers citing papers by Yingjun Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingjun Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingjun Xie. The network helps show where Yingjun Xie may publish in the future.

Co-authorship network of co-authors of Yingjun Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Yingjun Xie. A scholar is included among the top collaborators of Yingjun Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingjun Xie. Yingjun Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Taizhen, Yanmei Dong, Siqi Huang, et al.. (2025). A retrospective analysis on maternal and neonatal outcomes in pSS/AITD pregnancies. Scientific Reports. 15(1). 3437–3437.
2.
Wu, Jianfeng, Siqi Huang, Yinghong Yang, et al.. (2025). Development of patient-specific iPSC-based epilepsy models and identification of differentially expressed genes for disease mechanisms. Frontiers in Neuroscience. 19. 1582255–1582255.
3.
Huang, Siqi, et al.. (2025). Investigate the Effect of ZFP64 on mRNA Expression of HBG Based on Bioinformatics and Experimental Validation. Cell Biochemistry and Biophysics. 83(4). 4427–4437.
4.
Cai, Xiangsheng, et al.. (2024). Multi-omics study unravels gut microbiota and metabolites alteration in patients with Wilson's disease. Scientific Reports. 14(1). 21025–21025. 3 indexed citations
5.
Lin, Jie, et al.. (2023). NCAPG as a novel prognostic biomarker in numerous cancers: a meta-analysis and bioinformatics analysis. Aging. 15(7). 2503–2524. 4 indexed citations
6.
Sheng, Jiyao, Yongsheng Yang, Dan Zhang, et al.. (2022). End-to-End Invagination Pancreaticojejunostomy with Discontinuous U Suture in Pancreaticoduodenectomy. SSRN Electronic Journal.
8.
Wu, Jiacheng, Chao Lin, Yongsheng Yang, et al.. (2019). Pancreatic reconstruction techniques after pancreaticoduodenectomy: a review of the literature. Expert Review of Gastroenterology & Hepatology. 13(8). 797–806. 22 indexed citations
9.
Xie, Yingjun, Jian Du, Zefeng Liu, et al.. (2019). MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 7–7. 44 indexed citations
10.
Cui, Mengying, Hongdan Wang, Xiaoxiao Yao, et al.. (2019). Circulating MicroRNAs in Cancer: Potential and Challenge. Frontiers in Genetics. 10. 626–626. 330 indexed citations breakdown →
11.
Wu, Jiacheng, et al.. (2019). Bioinformatic Analysis of Circular RNA-Associated ceRNA Network Associated with Hepatocellular Carcinoma. BioMed Research International. 2019. 1–14. 26 indexed citations
12.
Xie, Yingjun, Jiyao Sheng, Dan Zhang, et al.. (2018). Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations. Journal of Immunology Research. 2018. 1–8. 48 indexed citations
13.
Zhang, Fan, Yawei Zhao, Kan He, et al.. (2018). Obesity-associated miR-27a upregulation promotes hepatocellular carcinoma metastasis through suppressing SFRP1. OncoTargets and Therapy. Volume 11. 3281–3292. 10 indexed citations
14.
Xie, Yingjun, Dan Zhang, Xiaoxiao Yao, et al.. (2018). Sarcomatoid carcinoma of the pancreas: A case report and review of the literature. Molecular Medicine Reports. 18(5). 4716–4724. 10 indexed citations
15.
Yao, Xiaoxiao, Xiaoning Li, Dan Zhang, et al.. (2017). B-cell lymphoma 2 inhibitor ABT-737 induces Beclin1- and reactive oxygen species-dependent autophagy in Adriamycin-resistant human hepatocellular carcinoma cells. Tumor Biology. 39(3). 3726131196–3726131196. 13 indexed citations
16.
Zhang, Lirong, Yu Hu, Ning Xi, et al.. (2016). Partial Oxygen Pressure Affects the Expression of Prognostic Biomarkers HIF‐1 Alpha, Ki67, and CK20 in the Microenvironment of Colorectal Cancer Tissue. Oxidative Medicine and Cellular Longevity. 2016(1). 1204715–1204715. 15 indexed citations
17.
Xie, Yingjun, et al.. (2014). Hiwi downregulation, mediated by shRNA, reduces the proliferation and migration of human hepatocellular carcinoma cells. Molecular Medicine Reports. 11(2). 1455–1461. 38 indexed citations
18.
Changyong, E, et al.. (2013). Combined Hepatocellular–Cholangiocarcinoma with Fever of Unknown Origin: A Case Report and Review of Literature. Cell Biochemistry and Biophysics. 69(1). 1–6. 3 indexed citations
19.
Song, Libing, Ting Dai, Yingjun Xie, et al.. (2011). Up-regulation of miR-1245 by c-myc targets BRCA2 and impairs DNA repair. Journal of Molecular Cell Biology. 4(2). 108–117. 37 indexed citations
20.
Xie, Yingjun, Christopher Cahill, Alexzander Asea, Philip E. Auron, & Stuart K. Calderwood. (1999). Heat shock proteins and regulation of cytokine expression. Infectious Diseases in Obstetrics and Gynecology. 7(1-2). 26–30. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026